Conventional and biological disease- modifying antirheumatic drugs and cardiovascular risk

Kardiovaskularni rizik (KVR) kod primjene konvencionalnih i biolokih bolest-modificirajuih lijekova je dosada iroko istraivan.Iako postoje razliiti zakljuci ovisno koji se parametar istrauje moe se zakljuiti da se adekvatnim lijeenjem upale smanjuje ukupni KVR

Publication Details

Journal
Reumatizam
Published
2025-11-04
DOI
https://doi.org/10.33004/reumatizam-supp-72-1-11
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Conventional and biological disease- modifying antirheumatic drugs and cardiovascular risk

Reumatizam
Rheumatoid Arthritis Research and Therapies
article

Conventional and biological disease- modifying antirheumatic drugs and cardiovascular risk

article en

Abstract

Kardiovaskularni rizik (KVR) kod primjene konvencionalnih i biolokih bolest-modificirajuih lijekova je dosada iroko istraivan.Iako postoje razliiti zakljuci ovisno koji se parametar istrauje moe se zakljuiti da se adekvatnim lijeenjem upale smanjuje ukupni KVR

Reumatizam
Good health and well-being
Openalex Percentile: Top 31%
Rheumatoid Arthritis Research and Therapies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Conventional and biological disease- modifying antirheumatic drugs and cardiovascular risk · Reumatizam (2025) | TGRS Research Map | TGRS